EU COMMITS €400M FOR VACCINE DEVELOPMENT

The European Union Monday committed 400 million Euros as guarantees to COVAX facility and its goals.

COVAX is the vaccine pillar of the Access to COVID-19 Tools Accelerator, a new, ground-breaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

More details in this video

0 0 vote
Article Rating

SHARE ON

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on telegram
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Related Posts

Eye Africa TV
0
Would love your thoughts, please comment.x
()
x
Scroll to Top